Also interesting
Univercells writes a new biomanufacturing chapter with Africa
Discover how Belgian biotech company Univercells Group intends to make vaccines accessible for everyone in Africa.
Takeda Invests Close to 300 Million Euros in its Plasma-Derived Therapies Production Site in Lessines
The investment encompasses a new production facility and a carbon net-zero emissions warehouse.
Visit of the Belgian sovereigns Philippe and Mathilde to Afrigen Biologics
During their state visit to South Africa last March, Queen Mathilde and King Philippe visited the Afrigen biologics facilities in Cape Town to learn more about how two Belgian companies, Univercells and Etherna, are supporting the development of the first African-owned mRNA COVID-19 vaccine to further discuss cooperation and partnership between the two countries and focus, among other things, on business and development.